BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36797828)

  • 21. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1.
    Wang YG; Wang T; Shi M; Zhai B
    J Exp Clin Cancer Res; 2019 Apr; 38(1):153. PubMed ID: 30971290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D; Lu X
    Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
    Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
    Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
    Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
    Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
    Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
    Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA POU6F2-AS2 is associated with oesophageal squamous cell carcinoma.
    Liu J; Sun X; Zhu H; Qin Q; Yang X; Sun X
    J Biochem; 2016 Oct; 160(4):195-204. PubMed ID: 27033944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP.
    Wang F; Tang C; Xu D; Tang Y; Jiang Y; Gao X; Xu J
    J Cell Mol Med; 2020 Apr; 24(8):4830-4838. PubMed ID: 32160650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of lncRNA HOXA-AS2 promotes the progression of oral squamous cell carcinoma by mediating SNX5 expression.
    Li Z
    BMC Mol Cell Biol; 2022 Dec; 23(1):59. PubMed ID: 36528556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Knockdown of lncRNA CACNA1C-AS2 promotes epithelial-mesenchymal transition and enhances the proliferation, invasion and migration of human esophageal cancer cells].
    Qin Y; Cao T; Xu Y; Jiang X; Ma J; Yu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):249-257. PubMed ID: 36946350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA EPB41L4A-AS2 represses Nasopharyngeal Carcinoma Metastasis by binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm.
    Du M; Hu X; Jiang X; Yin L; Chen J; Wen J; Fan Y; Peng F; Qian L; Wu J; He X
    Int J Biol Sci; 2021; 17(8):1963-1978. PubMed ID: 34131399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of miR-362 in Regulating the Proliferation, Invasion and Apoptosis of Gastric Cancer by Inhibiting the Expression of Tumor-Promoting Factor PRDM2.
    Wu RM; Pei ZJ; Zhang HQ; Gao Y; Duan XY
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):11-21. PubMed ID: 33639051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis.
    Hou G; Yang J; Tang J; He Y
    Cell Cycle; 2021 Jan; 20(2):179-193. PubMed ID: 33459113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
    Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
    J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4.
    Li W; Jin X; Zhao Y; Dai J; Cai Y
    Pathol Res Pract; 2020 Feb; 216(2):152772. PubMed ID: 31839366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis.
    Zhou Y; Sha Z; Yang Y; Wu S; Chen H
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.